VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $258,291 | -47.5% | 15,513 | -70.4% | 0.01% | -54.5% |
| Q4 2022 | $491,864 | +267.1% | 52,326 | +6.0% | 0.01% | +266.7% |
| Q3 2022 | $134,000 | -55.0% | 49,345 | -52.1% | 0.00% | -62.5% |
| Q2 2022 | $298,000 | +64.6% | 103,113 | +70.7% | 0.01% | +100.0% |
| Q1 2022 | $181,000 | -20.3% | 60,407 | +22.6% | 0.00% | -20.0% |
| Q4 2021 | $227,000 | -26.5% | 49,280 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $309,000 | -32.4% | 49,280 | -35.4% | 0.01% | -40.0% |
| Q2 2021 | $457,000 | -15.2% | 76,336 | -10.3% | 0.02% | -25.0% |
| Q1 2021 | $539,000 | +381.2% | 85,140 | +254.5% | 0.02% | +122.2% |
| Q1 2020 | $112,000 | -42.0% | 24,016 | 0.0% | 0.01% | -47.1% |
| Q4 2019 | $193,000 | -12.7% | 24,016 | +2.9% | 0.02% | -10.5% |
| Q2 2018 | $221,000 | +2.3% | 23,333 | -56.1% | 0.02% | -40.6% |
| Q4 2017 | $216,000 | – | 53,158 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |